Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Report to highlight N.J. drugmakers' progress in fight against cancer

9/14/2015

0 Comments

 
Trenton, NJ - According to Anjalee Khemlani of NJBiz, "A number of major New Jersey pharmaceutical companies are being monitored for progress on cancer cures. A report set to be released next Wednesday names more than 30 companies, including major players like Merck, Bristol-Myers Squibb, Novartis and Sanofi US."
The 146-page listing of all companies in the U.S. or working with U.S. firms highlights the ongoing push to kill America’s biggest killer.

This year, more than 1.6 million new cancer cases will be diagnosed, and almost 600,000 Americans will die from a form of the disease, according to the Pharmaceutical Research and Manufacturers of America, which released the report.

“The oncology research community has made significant advances in identifying new, more effective therapies to help people with cancer achieve positive treatment outcomes and transition from being cancer patients to cancer survivors,” said John Castellani, CEO and president of PhRMA. “However, the battle is far from over.”

The drugs listed in the report are in one of the various stages including development, awaiting approval from the Food and Drug Administration or in clinical trials.

More than 70 percent of the 836 medicines in the pipeline have the potential to be personalized medicine, according to PhRMA.

Since the early 1990s, cancer survival rates have increased 22 percent.

Pharma companies in New Jersey with medicines in the pipeline include:

·         AB Science USA

·         Advaxis

·         Allergan

·         Arno Therapeutics

·         Asana BioSciences

·         Bayer HealthCare Pharmaceuticals

·         Belrose Pharma

·         Bristol-Myers Squibb

·         Celgene

·         Celator Pharmaceuticals

·         CellDex Therapeutics

·         Celsion

·         Cornerstone Pharmaceuticals

·         Cyclacel Pharmaceuticals

·         Daiichi Sankyo

·         Eagle Pharmaceuticals

·         Eisai

·         Immunomedics

·         InnoPharma

·         Janssen Research & Development

·         Kyowa Hakko Kirin

·         Merck

·         Novartis

·         Nymox Pharmaceutical

·         PDS Biotechnology

·         PTC Therapeutics

·         Sanofi US

·         Soligenix

·         Taiho Oncology

·         Vicus Therapeutics

·         XEME Biopharma

For more on the report, click here.

0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.